Fate Therapeutics (FATE) Misses Q4 EPS by 1c, Revenues Miss

Go back to Fate Therapeutics (FATE) Misses Q4 EPS by 1c, Revenues Miss
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.23 +0.08 (3.72%)
Previous Close $2.15    52 Week High $4.76 
Open $2.10    52 Week Low $1.46 
Day High $2.32    P/E N/A 
Day Low $2.10    EPS $-1.91 
Volume 1,045,897